- Home
- HOPE vs ALMR Comparison
HOPE vs ALMR Comparison
Compare HOPE & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HOPE | ALMR |
|---|---|---|
| Founded | 1986 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2000 | 2026 |
Fundamental Metrics
Financial Performance| Metric | HOPE | ALMR |
|---|---|---|
| Price | $13.02 | $30.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $14.50 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 1.2M | 728.8K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.03 | $64.80 |
| Revenue Next Year | $20.77 | $37.27 |
| P/E Ratio | $17.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $21.58 |
| 52 Week High | $14.59 | $39.61 |
Technical Indicators
Market Signals| Indicator | HOPE | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 52.11 |
| Support Level | $12.95 | $23.87 |
| Resistance Level | $14.27 | $37.81 |
| Average True Range (ATR) | 0.37 | 2.56 |
| MACD | -0.05 | 0.20 |
| Stochastic Oscillator | 6.56 | 56.19 |
Price Performance
Historical ComparisonAbout HOPE Hope Bancorp Inc.
Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services, and other banking services.
About ALMR Alamar Biosciences Inc. Common Stock
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.